Category: BA.2.75.2
Preprint: Neutralizing antibody escape of BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
A recent preprint looks at the neutralizing antibody escape abilities for several new variants causing concern across the globe. More...
Growth advantage for BQ.1.1 is above 100% per week
The Omicron variant BQ.1.1 appears to be in a prime position to drive the coming winter wave in Europe. More...
BA.2.75.2 and BQ.1.1 approaching SARS-1 levels of escape
A new Twitter thread out today from Yunlong Cao gives further details about the variants BA.2.75 and BQ.1.1. More...
ECDC designates BA.2.75 a Variant of Concern
Marco Cavaleri, Head of Health Threats and Vaccines Strategy at the European Medicines Agency has revealed today that the Omicron variant BA.2.75 is now being monitored as a Variant of Concern (VOC) by the ECDC. More...
BA.2.75.2 “exhibits more extreme antibody escape than any variant we’ve seen so far”
Two preprints have been published over the last few days that give more details about the Omicron BA.2.75.2 sublineage. More...
BA.2.75.2: The “most immune evasive strain we have tested so far”
A Twitter post from Covid researcher Yunlong Cao claims that Omicron BA.2.75.2 is “currently the most immune evasive strain we have tested so far”. More...